| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4370
PTEN/MMAC1 is a major new tumor suppressor gene that encodes a dual-specificity phosphatase with sequence similarity to the cytoskeletal protein tensin. Recently, we reported that PTEN dephosphorylates focal adhesion kinase (FAK) and inhibits cell migration, spreading, and focal adhesion formation. Here, the effects of PTEN on cell invasion, migration, and growth as well as the involvement of FAK and p130 Crk-associated substrate (p130Cas) were investigated in U87MG glioblastoma cells missing PTEN. Cell invasion, migration, and growth were down-regulated by expression of phosphatase-active forms of PTEN but not by PTEN with an inactive phosphatase domain; these effects were correlated with decreased tyrosine phosphorylation levels of FAK and p130Cas. Overexpression of FAK concomitant with PTEN resulted in increased total tyrosine phosphorylation levels of FAK and p130Cas and effectively antagonized the effects of PTEN on cell invasion and migration and partially on cell growth. Overexpression of p130Cas increased total tyrosine phosphorylation levels of p130Cas without affecting those of FAK; however, although p130Cas could reverse PTEN inhibition of cell invasion and migration, it did not rescue cell growth in U87MG cells. In contrast to FAK, p130Cas could not be shown to interact with PTEN in cells, and it was not dephosphorylated directly by PTEN in vitro. These results suggest important roles of PTEN in the phenotype of tumor progression, and that the effects of PTEN on cell invasion, migration, and growth are mediated by distinct downstream pathways that diverge at the level of FAK.
This article has been cited by other articles:
![]() |
T. Miyamoto, M. Tamura, N. Kabashima, R. Serino, T. Shibata, Y. Furuno, M. Miyazaki, R. Baba, N. Sato, Y. Doi, et al. An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing Nephrol. Dial. Transplant., November 19, 2009; (2009) gfp601v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Desai, S. R. White, and C. M. Waters Mechanical stretch decreases FAK phosphorylation and reduces cell migration through loss of JIP3-induced JNK phosphorylation in airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L520 - L529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Fournier, J. E. Fata, K. J. Martin, P. Yaswen, and M. J. Bissell Interaction of E-cadherin and PTEN Regulates Morphogenesis and Growth Arrest in Human Mammary Epithelial Cells Cancer Res., May 15, 2009; 69(10): 4545 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, X. Jiang, Y. Shen, M. Li, H. Ma, M. Xing, and Y. Lu Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors Endocr. Relat. Cancer, March 1, 2009; 16(1): 301 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Milano, Y. Piao, T. LaFortune, and J. de Groot Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma Mol. Cancer Ther., February 1, 2009; 8(2): 394 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Renner, C. Blanco-Aparicio, M. Grassow, M. Canamero, J. F.M. Leal, and A. Carnero Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110{alpha} Predisposes Mammary Glands to Neoplastic Transformation Cancer Res., December 1, 2008; 68(23): 9643 - 9653. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dey, H. E. Crosswell, P. De, R. Parsons, Q. Peng, J. D. Su, and D. L. Durden The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration Cancer Res., March 15, 2008; 68(6): 1862 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Roberts, E. Ung, P. Whalen, B. Cooper, C. Hulford, C. Autry, D. Richter, E. Emerson, J. Lin, J. Kath, et al. Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271 Cancer Res., March 15, 2008; 68(6): 1935 - 1944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escriva, S. Peiro, N. Herranz, P. Villagrasa, N. Dave, B. Montserrat-Sentis, S. A. Murray, C. Franci, T. Gridley, I. Virtanen, et al. Repression of PTEN Phosphatase by Snail1 Transcriptional Factor during Gamma Radiation-Induced Apoptosis Mol. Cell. Biol., March 1, 2008; 28(5): 1528 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice Mol. Cancer Ther., March 1, 2008; 7(3): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi, S. Hanaka, T. Masuda, H. Yoshihara, H. Nagase, and K. Ohta Transduction of Phosphatase and Tensin Homolog Deleted on Chromosome 10 into Eosinophils Attenuates Survival, Chemotaxis, and Airway Inflammation J. Immunol., December 15, 2007; 179(12): 8105 - 8111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamguney and D. Stokoe New insights into PTEN J. Cell Sci., December 1, 2007; 120(23): 4071 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanco-Aparicio, O. Renner, J. F.M. Leal, and A. Carnero PTEN, more than the AKT pathway Carcinogenesis, July 1, 2007; 28(7): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Wu, K. McRoberts, and D Theodorescu The role of PTEN in prostate cancer cell tropism to the bone micro-environment Carcinogenesis, July 1, 2007; 28(7): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Diehl, E. T. Keller, and K. M. Woods Ignatoski Why should we still care about oncogenes? Mol. Cancer Ther., February 1, 2007; 6(2): 418 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Park, M.-J. Park, H.-J. Kwak, H.-C. Lee, M.-S. Kim, S.-H. Lee, I.-C. Park, C. H. Rhee, and S.-I. Hong Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8511 - 8519. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Packer, S. Pavey, A. Parker, M. Stark, P. Johansson, B. Clarke, P. Pollock, M. Ringner, and N. Hayward Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN Carcinogenesis, September 1, 2006; 27(9): 1778 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuwano PTEN as a New Agent in the Fight against Fibrogenesis Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
E. S. White, R. G. Atrasz, B. Hu, S. H. Phan, V. Stambolic, T. W. Mak, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, C. D. Kontos, et al. Negative Regulation of Myofibroblast Differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 112 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takino, M. Nakada, H. Miyamori, Y. Watanabe, T. Sato, D. Gantulga, K. Yoshioka, K. M. Yamada, and H. Sato JSAP1/JIP3 Cooperates with Focal Adhesion Kinase to Regulate c-Jun N-terminal Kinase and Cell Migration J. Biol. Chem., November 11, 2005; 280(45): 37772 - 37781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Liu, X. Sheng, Z. K. Hortobagyi, Z. Mao, G. E. Gallick, and W. K. A. Yung Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation Mol. Cell. Biol., July 15, 2005; 25(14): 6211 - 6224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W Stoker Protein tyrosine phosphatases and signalling J. Endocrinol., April 1, 2005; 185(1): 19 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, D. Ye, X. Xie, W. Lu, C. Zhu, and X. Chen PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles Reproductive Sciences, April 1, 2005; 12(3): 214 - 217. [Abstract] [PDF] |
||||
![]() |
B. Ferraro, G. Bepler, S. Sharma, A. Cantor, and E. B. Haura EGR1 Predicts PTEN and Survival in Patients With Non-Small-Cell Lung Cancer J. Clin. Oncol., March 20, 2005; 23(9): 1921 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Nathoo, A Chahlavi, G H Barnett, and S A Toms Pathobiology of brain metastases J. Clin. Pathol., March 1, 2005; 58(3): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stokoe and J. F. Costello Phosphatase and tensin homologue growth suppression without phosphatase PNAS, February 22, 2005; 102(8): 2677 - 2678. [Full Text] [PDF] |
||||
![]() |
E. S. White, R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden Prostaglandin E2 Inhibits Fibroblast Migration by E-Prostanoid 2 Receptor-Mediated Increase in PTEN Activity Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Lacalle, C. Gomez-Mouton, D. F. Barber, S. Jimenez-Baranda, E. Mira, C. Martinez-A., A. C. Carrera, and S. Manes PTEN regulates motility but not directionality during leukocyte chemotaxis J. Cell Sci., December 1, 2004; 117(25): 6207 - 6215. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ning, L. Pei, M. Liao, B. Liu, Y. Zhang, W. Jiang, J. G. Mielke, L. Li, Y. Chen, Y. H. El-Hayek, et al. Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN J. Neurosci., April 21, 2004; 24(16): 4052 - 4060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iijima, Y. E. Huang, H. R. Luo, F. Vazquez, and P. N. Devreotes Novel Mechanism of PTEN Regulation by Its Phosphatidylinositol 4,5-Bisphosphate Binding Motif Is Critical for Chemotaxis J. Biol. Chem., April 16, 2004; 279(16): 16606 - 16613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raftopoulou, S. Etienne-Manneville, A. Self, S. Nicholls, and A. Hall Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTEN Science, February 20, 2004; 303(5661): 1179 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, C. Domon-Dell, J. Kang, D. H. Chung, J.-N. Freund, and B. M. Evers Down-regulation of the Tumor Suppressor PTEN by the Tumor Necrosis Factor-{alpha}/Nuclear Factor-{kappa}B (NF-{kappa}B)-inducing Kinase/NF-{kappa}B Pathway Is Linked to a Default I{kappa}B-{alpha} Autoregulatory Loop J. Biol. Chem., February 6, 2004; 279(6): 4285 - 4291. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takino, H. Miyamori, Y. Watanabe, K. Yoshioka, M. Seiki, and H. Sato Membrane Type 1 Matrix Metalloproteinase Regulates Collagen-Dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration Cancer Res., February 1, 2004; 64(3): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. White, V. J. Thannickal, S. L. Carskadon, E. G. Dickie, D. L. Livant, S. Markwart, G. B. Toews, and D. A. Arenberg Integrin {alpha}4{beta}1 Regulates Migration across Basement Membranes by Lung Fibroblasts: A Role for Phosphatase and Tensin Homologue Deleted on Chromosome 10 Am. J. Respir. Crit. Care Med., August 15, 2003; 168(4): 436 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takino, M. Tamura, H. Miyamori, M. Araki, K. Matsumoto, H. Sato, and K. M. Yamada Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration J. Cell Sci., August 1, 2003; 116(15): 3145 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, X. Wang, W. Zhang, W. Reed, J. M. Samet, Y. E. Whang, and A. J. Ghio Zinc-induced PTEN Protein Degradation through the Proteasome Pathway in Human Airway Epithelial Cells J. Biol. Chem., July 18, 2003; 278(30): 28258 - 28263. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. A. Zhang, B. He, B. Zhou, and L. Liu Requirement of the p130CAS-Crk Coupling for Metastasis Suppressor KAI1/CD82-mediated Inhibition of Cell Migration J. Biol. Chem., July 11, 2003; 278(29): 27319 - 27328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Su, L. D. Mayo, D. B. Donner, and D. L. Durden PTEN and Phosphatidylinositol 3'-Kinase Inhibitors Up-Regulate p53 and Block Tumor-induced Angiogenesis: Evidence for an Effect on the Tumor and Endothelial Compartment Cancer Res., July 1, 2003; 63(13): 3585 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takino, M. Nakada, H. Miyamori, J. Yamashita, K. M. Yamada, and H. Sato CrkI Adapter Protein Modulates Cell Migration and Invasion in Glioblastoma Cancer Res., May 1, 2003; 63(9): 2335 - 2337. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mareel and A. Leroy Clinical, Cellular, and Molecular Aspects of Cancer Invasion Physiol Rev, April 1, 2003; 83(2): 337 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marino, P. Krimpenfort, C. Leung, H. A. G. M. van der Korput, J. Trapman, I. Camenisch, A. Berns, and S. Brandner PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum Development, March 9, 2003; 129(14): 3513 - 3522. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugatani, U. Alvarez, and K. A. Hruska PTEN Regulates RANKL- and Osteopontin-stimulated Signal Transduction during Osteoclast Differentiation and Cell Motility J. Biol. Chem., February 7, 2003; 278(7): 5001 - 5008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Park, M.-S. Kim, I.-C. Park, H.-S. Kang, H. Yoo, S. H. Park, C. H. Rhee, S.-I. Hong, and S.-H. Lee PTEN Suppresses Hyaluronic Acid-induced Matrix Metalloproteinase-9 Expression in U87MG Glioblastoma Cells through Focal Adhesion Kinase Dephosphorylation Cancer Res., November 1, 2002; 62(21): 6318 - 6322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Knobbe, A. Merlo, and G. Reifenberger Pten signaling in gliomas Neuro-oncol, July 1, 2002; 4(3): 196 - 211. [Abstract] [PDF] |
||||
![]() |
J. A. Fox, K. Ung, S. G. Tanlimco, and F. R. Jirik Disruption of a Single Pten Allele Augments the Chemotactic Response of B Lymphocytes to Stromal Cell-Derived Factor-1 J. Immunol., July 1, 2002; 169(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sun and B. M. Steinberg PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells J. Gen. Virol., June 1, 2002; 83(7): 1651 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santos, J. M. Paramio, A. Bravo, A. Ramirez, and J. L. Jorcano The Expression of Keratin K10 in the Basal Layer of the Epidermis Inhibits Cell Proliferation and Prevents Skin Tumorigenesis J. Biol. Chem., May 17, 2002; 277(21): 19122 - 19130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Levine, T. Forest, and C. Smith Tumor Suppressor PTEN is Mutated in Canine Osteosarcoma Cell Lines and Tumors Vet. Pathol., May 1, 2002; 39(3): 372 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Soria, H.-Y. Lee, J. I. Lee, L. Wang, J.-P. Issa, B. L. Kemp, D. D. Liu, J. M. Kurie, L. Mao, and F. R. Khuri Lack of PTEN Expression in Non-Small Cell Lung Cancer Could Be Related to Promoter Methylation Clin. Cancer Res., May 1, 2002; 8(5): 1178 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. van Golen, T. S. Schwab, K. M. W. Ignatoski, S. P. Ethier, and E. L. Feldman PTEN/MMAC1 Overexpression Decreases Insulin-like Growth Factor-I-mediated Protection from Apoptosis in Neuroblastoma Cells Cell Growth Differ., July 1, 2001; 12(7): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Mutter PTEN, a Protean Tumor Suppressor Am. J. Pathol., June 1, 2001; 158(6): 1895 - 1898. [Full Text] [PDF] |
||||
![]() |
M. Yasuda, Y. Tanaka, M. Tamura, K. Fujii, M. Sugaya, T. So, M. Takenoyama, and K. Yasumoto Stimulation of {beta}1 Integrin Down-Regulates ICAM-1 Expression and ICAM-1-dependent Adhesion of Lung Cancer Cells through Focal Adhesion Kinase Cancer Res., March 1, 2001; 61(5): 2022 - 2030. [Abstract] [Full Text] |
||||
![]() |
N. Prasad, R. S. Topping, and S. J. Decker SH2-Containing Inositol 5'-Phosphatase SHIP2 Associates with the p130Cas Adapter Protein and Regulates Cellular Adhesion and Spreading Mol. Cell. Biol., February 15, 2001; 21(4): 1416 - 1428. [Abstract] [Full Text] |
||||
![]() |
K. M. Yamada and M. Araki Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis J. Cell Sci., January 7, 2001; 114(13): 2375 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Hong, P.-C. Yang, K. Peck, J. J. W. Chen, S.-C. Yang, Y.-C. Chen, and C.-W. Wu Profiling the Downstream Genes of Tumor Suppressor PTEN in Lung Cancer Cells by Complementary DNA Microarray Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 355 - 363. [Abstract] [Full Text] |
||||
![]() |
M. TAMURA, N. YANAGIHARA, H. TANAKA, A. OSAJIMA, T. HIRANO, K. HIGASHI, K. M. YAMADA, Y. NAKASHIMA, and H. HIRANO Activation of DNA Synthesis and AP-1 by Profilin, an Actin-Binding Protein, via Binding to a Cell Surface Receptor in Cultured Rat Mesangial Cells J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1620 - 1630. [Abstract] [Full Text] |
||||
![]() |
G. L. Maxwell, J. I. Risinger, K. A. Hayes, A. A. Alvarez, R. K. Dodge, J. C. Barrett, and A. Berchuck Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers Clin. Cancer Res., August 1, 2000; 6(8): 2999 - 3005. [Abstract] [Full Text] |
||||
![]() |
A. H. Holway, K. M. Rieger-Christ, W. R. Miner, J. W. Cain, J. M. Dugan, J. A. Pezza, M. L. Silverman, A. Shapter, R. McLellan, and I. C. Summerhayes Somatic Mutation of PTEN in Vulvar Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3228 - 3235. [Abstract] [Full Text] |
||||
![]() |
G. L. Mutter, M.-C. Lin, J. T. Fitzgerald, J. B. Kum, and C. Eng Changes in Endometrial PTEN Expression throughout the Human Menstrual Cycle J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2334 - 2338. [Abstract] [Full Text] |
||||
![]() |
S.-Y. Han, H. Kato, S. Kato, T. Suzuki, H. Shibata, S. Ishii, K.-i. Shiiba, S. Matsuno, R. Kanamaru, and C. Ishioka Functional Evaluation of PTEN Missense Mutations Using in Vitro Phosphoinositide Phosphatase Assay Cancer Res., June 1, 2000; 60(12): 3147 - 3151. [Abstract] [Full Text] |
||||
![]() |
O. Gimm, A. Perren, L.-P. Weng, D. J. Marsh, J. J. Yeh, U. Ziebold, E. Gil, R. Hinze, L. Delbridge, J. A. Lees, et al. Differential Nuclear and Cytoplasmic Expression of PTEN in Normal Thyroid Tissue, and Benign and Malignant Epithelial Thyroid Tumors Am. J. Pathol., May 1, 2000; 156(5): 1693 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Lee, C. L. Reimer, L. Fang, M. L. Iruela-Arispe, and S. A. Aaronson Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression Mol. Cell. Biol., March 1, 2000; 20(5): 1723 - 1732. [Abstract] [Full Text] |
||||
![]() |
M. TAMURA, H. TANAKA, A. YASHIRO, A. OSAJIMA, M. OKAZAKI, H. KUDO, Y. DOI, S. FUJIMOTO, K. HIGASHI, Y. NAKASHIMA, et al. Expression of Profilin, an Actin-Binding Protein, in Rat Experimental Glomerulonephritis and Its Upregulation by Basic Fibroblast Growth Factor in Cultured Rat Mesangial Cells J. Am. Soc. Nephrol., March 1, 2000; 11(3): 423 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brinkman, S. van der Flier, E. M. Kok, and L. C. J. Dorssers BCAR1, a Human Homologue of the Adapter Protein p130Cas, and Antiestrogen Resistance in Breast Cancer Cells J Natl Cancer Inst, January 19, 2000; 92(2): 112 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. v. d. Flier, A. Brinkman, M. P. Look, E. M. Kok, M. E. Meijer-van Gelder, J. G. M. Klijn, L. C. J. Dorssers, and J. A. Foekens Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment J Natl Cancer Inst, January 19, 2000; 92(2): 120 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen, P. Lyons, M. Cooley, D. Davidson, A. Veillette, R. Salgia, J. D. Griffin, and M. D. Schaller The Noncatalytic Domain of Protein-tyrosine Phosphatase-PEST Targets Paxillin for Dephosphorylation in Vivo J. Biol. Chem., January 14, 2000; 275(2): 1405 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Wang, J. Grammer, C. Cobbs, J. Stewart, Z Liu, R Rhoden, T. Hecker, Q Ding, and C. Gladson p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo J. Cell Sci., January 12, 2000; 113(23): 4221 - 4230. [Abstract] [PDF] |
||||
![]() |
N. B. Adey, L. Huang, P. A. Ormonde, M. L. Baumgard, R. Pero, D. V. Byreddy, S. V. Tavtigian, and P. L. Bartel Threonine Phosphorylation of the MMAC1/PTEN PDZ Binding Domain Both Inhibits and Stimulates PDZ Binding Cancer Res., January 1, 2000; 60(1): 35 - 37. [Abstract] [Full Text] |
||||
![]() |
I. U. Ali, L. M. Schriml, and M. Dean Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity J Natl Cancer Inst, November 17, 1999; 91(22): 1922 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamura, J. Gu, H. Tran, and K. M. Yamada PTEN Gene and Integrin Signaling in Cancer J Natl Cancer Inst, November 3, 1999; 91(21): 1820 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Maier, G. Jones, X. Li, A. H. Schonthal, O. Gratzl, E. G. Van Meir, and A. Merlo The PTEN Lipid Phosphatase Domain Is Not Required to Inhibit Invasion of Glioma Cells Cancer Res., November 1, 1999; 59(21): 5479 - 5482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hahn, I. Wieland, O. N. Koufaki, H. Gorgens, S. B. Sobottka, G. Schackert, and H. K. Schackert Genetic Alterations of the Tumor Suppressor Gene PTEN/MMAC1 in Human Brain Metastases Clin. Cancer Res., September 1, 1999; 5(9): 2431 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu, M. Tamura, R. Pankov, E. H.J. Danen, T. Takino, K. Matsumoto, and K. M. Yamada Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten J. Cell Biol., July 26, 1999; 146(2): 389 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamura, J. Gu, E. H. J. Danen, T. Takino, S. Miyamoto, and K. M. Yamada PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway J. Biol. Chem., July 16, 1999; 274(29): 20693 - 20703. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. W. Cheney, S. T. C. Neuteboom, M.-T. Vaillancourt, M. Ramachandra, and R. Bookstein Adenovirus-mediated Gene Transfer of MMAC1/PTEN to Glioblastoma Cells Inhibits S Phase Entry by the Recruitment of p27Kip1 into Cyclin E/CDK2 Complexes Cancer Res., May 1, 1999; 59(10): 2318 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sieg, C. Hauck, and D. Schlaepfer Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration J. Cell Sci., January 8, 1999; 112(16): 2677 - 2691. [Abstract] [PDF] |
||||
![]() |
F. Xu, R. Zhao, Y. Peng, A. Guerrah, and Z. J. Zhao Association of Tyrosine Phosphatase SHP-2 with F-actin at Low Cell Densities J. Biol. Chem., July 27, 2001; 276(31): 29479 - 29484. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kotelevets, J. van Hengel, E. Bruyneel, M. Mareel, F. van Roy, and E. Chastre The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness J. Cell Biol., December 24, 2001; 155(7): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Bellas, E. O. Harrington, K. L. Sheahan, J. Newton, C. Marcus, and S. Rounds FAK blunts adenosine-homocysteine-induced endothelial cell apoptosis: requirement for PI 3-kinase Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1135 - L1142. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |